Novo Nordisk pioneered the event of GLP-1 medication for metabolic issues, however the merchandise nonetheless consist primarily of once-a-week injections. The Danish pharmaceutical large is investing $285 million to launch a strategic alliance that may give the pharmaceutical large entry to Ascendis Pharma expertise that enables its medication to be dosed each 4 weeks. The lead product candidate for the […]
